Lexaria Bioscience Corp. (LEXX) vs Xenetic Biosciences, Inc. (XBIO)
A side-by-side comparison of Lexaria Bioscience Corp. and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LEXX
Lexaria Bioscience Corp.
$3.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XBIO
Xenetic Biosciences, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LEXX vs XBIO
growth of $100 · dividends reinvested · last 6yLEXX -95.9% (-41.2%/yr)XBIO -91.8% (-34.1%/yr)XBIO compounded faster over this window
LEXX XBIO
LEXX vs XBIO: by the numbers
- •LEXX is the larger company ($5M vs $5M market cap).
- •Both run net losses; XBIO's is the smaller (-75.90% vs -3985.58% net margin).
- •XBIO grew revenue faster over the past five years (34.31% vs 12.92% CAGR).
Metrics side by side
Valuation
| Metric | LEXX | XBIO |
|---|---|---|
| P/S ratio | 27.60 | 1.49 |
| P/B ratio | 1.13 | 0.80 |
Profitability
| Metric | LEXX | XBIO |
|---|---|---|
| Gross margin | 100.00% | 100.00% |
| Operating margin | -1683.01% | -95.23% |
| Net margin | -3985.58% | -75.90% |
| ROE | -163.18% | -40.76% |
| ROIC | -175.26% | -43.50% |
Growth (annualized)
| Metric | LEXX | XBIO |
|---|---|---|
| Revenue CAGR (5Y) | 12.92% | 34.31% |
| Total return CAGR (5Y) | -50.86% | -34.54% |
Frequently asked
- Which has grown faster, LEXX or XBIO?
- Over the past five years, XBIO grew revenue faster — LEXX at a 12.92% CAGR versus XBIO at 34.31%.
- How have LEXX and XBIO total returns compared?
- Over the past 5 years, LEXX delivered -50.86% and XBIO delivered -34.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Lexaria Bioscience ROEXenetic Biosciences ROELexaria Bioscience operating marginXenetic Biosciences operating marginLexaria Bioscience revenue growthXenetic Biosciences revenue growthLexaria Bioscience free cash flowXenetic Biosciences free cash flow
Lexaria Bioscience & Xenetic Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.